data13F

SLS – Sellas Life Sciences Group I

Held by 2 of 60 tracked investors in their latest 13F filing · 1 counted on Most owned (narrow-view filings excluded)

Investors holding2
Combined shares380,778
Combined reported value$4.7M

SLS chart by TradingView. Live prices are TradingView's; all other numbers on this page are from 13F filings.

Ownership

Investor% of their portfolioChangeSharesReported valuePeriod
Polen Capital 0.03 New218,091$2.7MQ3 2026
Paul Tudor Jones narrow view 0.01 New162,687$2.0MQ3 2026

Activity: last 4 quarters

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Polen Capital New218,0910.03
Q3 2026Paul Tudor Jones narrow view New162,6870.01

Added: opened or increased

PeriodInvestorChangeShares afterEffect on their portfolio (pts)
Q3 2026Polen Capital New218,0910.03
Q3 2026Paul Tudor Jones narrow view New162,6870.01

Reduced: reduced or closed

No tracked investor reduced or closed this position in the last 4 quarters.

History

Shares held, last 8 quarters

InvestorQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Polen Capital218.1K–––––––
Paul Tudor Jones162.7K–––––––

– = not held that quarter. n/a = no holdings report for that quarter (not filed yet, or reported under another manager).